Jan J. Cornelissen

European Medicines Agency — Netherlands

Medicine · Health Sciences

78h-index31.5kcitations610works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(310), Acute Myeloid Leukemia Research(263), Acute Lymphoblastic Leukemia research(165), Chronic Myeloid Leukemia Treatments(125), Immune Cell Function and Interaction(69)

Publications610 total

Adaptive designs in randomized clinical trials: reanalysis of the HOVON87/NMSG18 multiple myeloma trial
EClinicalMedicine·2025Open Access
The added value of Bayesian interim analysis in randomized phase II and phase III clinical trials in hemato-oncology
Haematologica·2025Open Access
Dynamic Prediction of Progression Based on Minimal Residual Disease (MRD) in Patients with Newly Diagnosed Transplant Eligible Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia·2025
Beyond traditional endpoints: A multi-state modelling approach to integrating morbidity and mortality in cancer treatments evaluation
European Journal of Cancer·2025Open Access
Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B‐ALL, or T‐ALL
HemaSphere·2025· 2 citedOpen Access
Real-time data in cancer registries: Validation of an automated data extraction system
iScience·2025· 2 citedOpen Access
Borrowing from the past to test the future: Innovative approaches to prospective clinical trials in rare cancers
European Journal of Cancer·2025Open Access
Immunotherapy for rapid bone marrow conditioning and leukemia depletion that allows efficient hematopoietic stem cell transplantation
Journal for ImmunoTherapy of Cancer·2025Open Access
Comparability of external and internal control patients for the prospective randomized <scp>HOVON</scp> ‐103 trial in older <scp>AML</scp> patients
British Journal of Haematology·2025Open Access
It takes two to tango: allogeneic stem cell transplantation and FLT3 tyrosin kinase inhibitor therapy
Haematologica·2025Open Access
A revised prognostic model for patients with acute myeloid leukemia and first relapse
Blood Advances·2025Open Access
Impact of shared HLA determinants between patient and losing cord blood unit on relapse after double cord blood transplantation
Blood Advances·2025· 4 citedOpen Access
Treatment‐Free Remission Outcomes in a <i><scp>BCR</scp>::<scp>ABL1</scp></i> Digital <scp>PCR</scp> Selected Clinical Cohort of <scp>CML</scp> Patients
European Journal Of Haematology·2025· 2 citedOpen Access
The association between hospital volume and overall survival in adult AML patients treated with intensive chemotherapy
ESMO Open·2025Open Access
Sustained treatment-free remission in two chronic myeloid leukemia patients after asciminib discontinuation: a report of two cases
Annals of Hematology·2025· 2 citedOpen Access
Time‐restricted versus standard‐duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON‐96 trial
HemaSphere·2024Open Access
BCR::ABL1 Deep Molecular Response Quantification and Transcript Type Identification in Chronic Myeloid Leukemia Using a US Food and Drug Administration–Approved Droplet-Based Digital PCR Assay
Journal of Molecular Diagnostics·2024· 3 citedOpen Access
The Influence of HLA Matching of the Winning and Losing Units in Relapse of Patients Receiving Double Cord Blood Transplantation for Acute Leukemia or Myelodysplastic Syndrome
Blood·2024· 1 citedOpen Access
Transcriptional Profiling Directs the Classification of Mixed Phenotype Acute Leukemias into AML, B-ALL or T-ALL
Blood·2024Open Access
Post-transplant cyclophosphamide separates graft-versus host disease and graft versus leukemia effects after HLA-matched stem-cell transplantation for acute myeloid leukemia
Leukemia·2024· 6 citedOpen Access
page 1 of 31Next →

Frequent Co-authors

Bob Löwenberg(14), Mohamad Mohty(12), Aloïs Gratwohl(9), Arnon Nagler(8), Leo F. Verdonck(7), Dietger Niederwieser(7), Andrea Bacigalupo(6), Gèrard Socié(6), Bronno van der Holt(6), Myriam Labopin(6), Fabio Ciceri(5), Sebastian Giebel(5), Nicolaus Kröger(5), Marinus van Marwijk Kooy(5), Pierre W. Wijermans(5), Harry C. Schouten(5), Johan Maertens(5), Joost W. J. van Esser(5), Gert J. Ossenkoppele(5), Vanderson Rocha(5)